Fact CheckerSign in

NCT06606080Completed

The Relationship Between Time Perspective, Fear of Cancer Recurrence, Rumination, and Catastrophizing in Gastric Cancer Survivors

The Formation Pathway of Fear of Cancer Recurrence in Gastric Cancer Survivors From a Time Perspective

Source: ClinicalTrials.gov · Last updated 20 Sept 2024

Brief summary (registry, in English)

The temporal perspective provides a theory oriented to temporal insights that can shed light on the role of cognitive coping styles in the formation of fear of cancer recurrence. The self-regulatory executive function model elucidates the central role of rumination thinking, catastrophizing cognitive coping styles in the formation of cancer recurrence fear. Therefore, this study will rely on both theoretical models to construct a cognitive appraisal coping model to explore the formation pathway of cancer recurrence fear

Status (registry)
Completed
Study type
Observational
Enrollment
340 (actual)
First submitted
17 Sept 2024
Start date
10 Aug 2023
Primary completion date
1 Sept 2024
Lead sponsor
Ting Wang
NCT number
NCT06606080

What you commit to

  • Study type: Observational
  • Participants enrolled: 340
  • From 10 Aug 2023 to the primary completion date, 1 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • ● History of mental or cognitive impairment prior to cancer diagnosis

Who the study is looking for

  • Preoperative gastroscopy and pathological diagnosis of gastric cancer;
  • Aged 18 years or older
  • There is no history of recurrent disease or new primary cancer
  • Received surgical resection of cancerous tissues or radiotherapy treatment
  • Conscious, with normal communication and comprehension ability
  • The patients were aware of their own condition and diagnosis, and informedly agreed to participate in this study

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jiangsu
Coordinator of this site? Confirm its status
NanjingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.